Intersect ENT OverviewIntersect ENT EBIT
EBIT (Earnings Before Interest and Taxes) analysis for XENT.
Quarterly EBIT
-$26.75M
↓ 40.21% YoY
As of Mar 31, 2022
Annual EBIT (TTM)
-$162.56M
↓ 127.27% YoY
Trailing 12 months ending Mar 31, 2022
Intersect ENT OverviewEBIT (Earnings Before Interest and Taxes) analysis for XENT.
As of Mar 31, 2022
Trailing 12 months ending Mar 31, 2022